Abdelhakim Dinar, MD Psychiatry & Neurology - Clinical Neurophysiology Medicare: Accepting Medicare Assignments Practice Location: 711 Troy Schenectady Road, Suite 207, Latham, NY 12110 Phone: 518-867-3030 Fax: 518-867-3033 |
William Wagle, Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 711 Troy Schenectady Rd, Suite 114, Latham, NY 12110 Phone: 518-786-1600 |
Dr. Abdul S. Khan, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 711 Troy Schenectady Rd Ste 207, Latham, NY 12110 Phone: 518-867-3030 |
Saad Khan, D.O Psychiatry & Neurology - Psychosomatic Medicine Medicare: Accepting Medicare Assignments Practice Location: 1205 Troy Schenectady Rd Ste 101, Latham, NY 12110 Phone: 518-348-3176 |
Dr. Rocco M Zaninelli, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 11 Century Hill Drive, Latham, NY 12110 Phone: 518-713-4595 Fax: 518-713-4598 |
News Archive
This is Africa reports on how changing priorities for major generic drug producing countries, such as Brazil, India and China - countries that "redefined affordable drugs, making access to medicines possible for millions in low-income regions" - and greater adoption of intellectual property rules could reshape the African pharmaceutical landscape, potentially leading to price increases, according to some experts.
Many cancers could be successfully treated if the patient consulted the doctor sufficiently early. But how can a developing cancer be detected if it doesn't give rise to any symptoms? In the near future, suitably early diagnosis could be provided by simple and cheap chemical sensors - thanks to special recognizing polymer films developed at the Institute of Physical Chemistry of the Polish Academy of Sciences in Warsaw.
Researchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer's disease (AD) that could lead to therapies focused on treating the neurodegenerative condition early in its progression.
President Donald Trump keeps promising to unveil a comprehensive plan to replace the Affordable Care Act, but it keeps not appearing.
Spinal Muscular Atrophy is one of many serious disorders for which prenatal testing is available. SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive disorder, after cystic fibrosis. Although the American College of Medical Genetics recommends carrier testing for all couples, the American College of Obstetricians and Gynecologists has issued a recommendation to the contrary, citing lack of information about the costs and benefits of screening for SMA.
› Verified 9 days ago